Suchergebnisse - "Heilig, Bernhard"

PubPharm (13)

1

The iTOP trial : Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cancer - A prospective, controlled, single-center study

enthalten in: International journal of surgery (London, England) | 2022

von Bolliger, M. | Lanmüller, P. | Schuetz, M. | +12

2

Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA) : a double-blind, multicentre, randomised controlled trial

enthalten in: Lancet (London, England) | 2020

von Burmester, G. | Buttgereit, F. | Bernasconi, C. | +57

CommentIn: Lancet. 2020 Jul 25;396(10246):218-219. - PMID 32711782

3

T-786C single nucleotide polymorphism of the endothelial nitric oxide synthase gene as a risk factor for endothelial dysfunction in polymyalgia rheumatica

enthalten in: Clinical and experimental rheumatology | 2015

von Löffers, C. | Heilig, B. | Hecker, M.

4

T-786C single nucleotide polymorphism of the endothelial nitric oxide synthase gene as a risk factor for endothelial dysfunction in polymyalgia rheumatica

enthalten in: Clinical and experimental rheumatology | 27 August 2015

von Löffers, C. | Heilig, B. | Hecker, M.

5

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA) : a randomised, double-blind, controlled phase 4 trial

enthalten in: Lancet (London, England) | 2013

von Gabay, C. | Emery, P. | van Vollenhoven, R. | +85

ErratumIn: Lancet. 2013 Dec 7;382(9908):1878

6

Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers

enthalten in: International journal of cancer | 2008

von Reuschenbach, M. | Waterboer, T. | Wallin, K. | +10

7

Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers

enthalten in: International journal of cancer | 2008

von Reuschenbach, M. | Waterboer, T. | Wallin, K. | +10

8

Immunogenicity, efficacy and adverse events of adalimumab in RA patients

enthalten in: Rheumatology international | 2007

von Bender, N. | Heilig, C. | Dröll, B. | +3

9

Immunogenicity, efficacy and adverse events of adalimumab in RA patients

enthalten in: Rheumatology international | 2006

von Bender, N. | Heilig, C. | Dröll, B. | +3

10

Immunogenicity, efficacy and adverse events of adalimumab in RA patients

enthalten in: Rheumatology international | 2006

von Bender, N. | Heilig, C. | Dröll, B. | +3